Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vicriviroc + Pembrolizumab in Advanced/Metastatic MSS CRC
NCT03631407Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vicriviroc in colorectal cancer (CRC), sponsored by Merck & Co.. Started Sep 2018; status: completed.
02
Drugs
vicriviroc
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03631407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03631407.